Home
Conditions
Immunotherapy

Clinical trial condition

Immunotherapy

Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.

216 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Immunotherapy trial results

Recruiting

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

NCT03198546

Conditions: Adenocarcinoma, CAR, Carcinoma, +15 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

NCT05266846

Conditions: ALK Gene Mutation, Adenocarcinoma, Adenocarcinoma of Lung, +10 more
Locations: Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Recruiting

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

NCT06429839

Conditions: Chemoradiotherapy, Chemotherapy, Digestive System Diseases, +11 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

NCT06410651

Conditions: Chemoradiotherapy, Chemotherapy, Digestive System Diseases, +11 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

NCT06391190

Conditions: Concurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Cervical Carcinoma
Locations: RenJi hospital Shanghai, China

View Trial Details

Recruiting

Toripalimab Combined With Definitive CCRT for LACC Patients

NCT06256224

Conditions: Cervical Cancer, Chemoradiotherapy, Female Urogenital Diseases, +13 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Immunotherapy for Hepatocellular Carcinoma

NCT06241326

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma

NCT06313450

Conditions: Carcinoma, Head and Neck Neoplasms, Immunotherapy, +13 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NCT06037733

Conditions: Advanced Non-Small Cell Squamous Lung Cancer, Immunotherapy, Radiotherapy
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NCT06020430

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Immunotherapy

Immunotherapy trial results

Related conditions